cp-55,940 has been researched along with jwh 018 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blaazer, AR; den Boon, FS; Kruse, CG; Lange, JH; Mulder, A; van der Neut, MA; Wadman, WJ; Werkman, TR | 1 |
| Bratton, SM; Brents, LK; Chimalakonda, KC; Endres, GW; Hollenberg, PF; James, LP; Moran, CL; Moran, JH; Prather, PL; Radominska-Pandya, A; Seely, KA | 1 |
| Buzard, DJ; Han, S; Jones, RM; Thatte, J | 1 |
| Chung, S; Dangott, LJ; Huang, H; Kier, AB; Landrock, D; Landrock, KK; Li, S; Martin, GG; McIntosh, AL; Schroeder, F | 1 |
1 review(s) available for cp-55,940 and jwh 018
| Article | Year |
|---|---|
Therapeutic utility of cannabinoid receptor type 2 (CB(2)) selective agonists.
Topics: Animals; Drug Design; Humans; Ligands; Models, Molecular; Molecular Conformation; Receptor, Cannabinoid, CB2; Structure-Activity Relationship; Substrate Specificity | 2013 |
3 other study(ies) available for cp-55,940 and jwh 018
| Article | Year |
|---|---|
Novel indole and azaindole (pyrrolopyridine) cannabinoid (CB) receptor agonists: design, synthesis, structure-activity relationships, physicochemical properties and biological activity.
Topics: Animals; Brain; Cannabinoid Receptor Agonists; CHO Cells; Cricetinae; Humans; Indoles; Ligands; Male; Rats; Rats, Wistar; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Structure-Activity Relationship | 2011 |
Cytochrome P450-mediated oxidative metabolism of abused synthetic cannabinoids found in K2/Spice: identification of novel cannabinoid receptor ligands.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Brain; Cannabinoids; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2C9; Cytochrome P-450 Enzyme System; Dronabinol; Humans; Hydroxylation; Illicit Drugs; Indoles; Kinetics; Ligands; Liver; Mass Spectrometry; Mice; Microsomes, Liver; Naphthalenes; Oxidation-Reduction; Protein Binding; Pyrans; Receptor, Cannabinoid, CB1 | 2012 |
FABP1: A Novel Hepatic Endocannabinoid and Cannabinoid Binding Protein.
Topics: Animals; Endocannabinoids; Fatty Acid-Binding Proteins; Female; Fluorescent Dyes; Humans; Liver; Male; Mice; Mice, Inbred C57BL; Receptors, Cannabinoid | 2016 |